Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3

Genomics
I Bouyge-MoreauM C Devilder

Abstract

A putative tumor suppressor gene involved in B cell chronic lymphocytic leukemia (B-CLL) was mapped to human chromosome 13q14.3 close to the genetic markers D13S25 and D13S319. We constructed a 780-kb-long contig composed of cosmids, bacterial artificial chromosomes, and bacteriophage P1-derived artificial chromosomes that provides essential information and tools for the positional cloning of this gene. The conting contains both flanking markers as well as several additional genetic markers, three ESTs, and one potential CpG island. In addition, using one B-CLL patient, we characterized a small internal deleted region of 550 kb. Comparing this deletion with other recently published deletions narrows the minimally deleted area to less than 100 kb in our physical map. This deletion core region should contain all or part of the disrupted in B cell malignancies tumor suppressor gene.

References

Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·H ShizuyaM Simon
Apr 1, 1990·Cancer Genetics and Cytogenetics·G Juliusson, G Gahrton
Feb 1, 1990·Genomics·G M FordA J Becker
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D L NelsonC T Caskey
Jul 1, 1983·Analytical Biochemistry·A P Feinberg, B Vogelstein
Sep 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y LiuS Einhorn

❮ Previous
Next ❯

Citations

Sep 1, 2001·British Journal of Haematology·V Brito-BabapulleD Catovsky
Aug 7, 2001·Reviews in Clinical and Experimental Hematology·S StilgenbauerH Döhner
Sep 6, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter OuilletteSami N Malek
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Apr 25, 2007·Cancer Genetics and Cytogenetics·Stephanie StruskiMichel Lessard
Jan 20, 2000·Baillière's Clinical Haematology·A J BenchA R Green
Aug 25, 2004·Hematology/oncology Clinics of North America·Stephan Stilgenbauer, Hartmut Döhner
Dec 4, 2002·Genes, Chromosomes & Cancer·Manal O ElnenaeiDaniel Catovsky
Jun 1, 2002·Leukemia·S StilgenbauerUNKNOWN German CLL Study Group (GCLLSG). Chronic lymphocytic leukemia
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jane HouldsworthR S K Chaganti
Jul 10, 1999·Current Opinion in Hematology·W G Wierda, T J Kipps

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.